Inventor

Wei Yao

Inventor
New Milford, NJ, US

Overview

17→
Patents
2009–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07KPeptides7%
H01BCables2%
H04NPictorial communication, e.g. television2%
PatentTitleYear
11,120,924Cable and a combined cable202111,039,081Image sensor capable of eliminating rolling flicker and adjusting frame rate202110,799,500Organic compounds202010,716,786Transmucosal and subcutaneous compositions202010,688,097Organic compounds202010,597,395Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof202010,494,401LLP2A-bisphosphonate conjugates for osteoporosis treatment201910,464,938Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof201910,245,260Organic compounds201910,221,176Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof20199,751,883'Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof'20179,561,256'LLP2A-bisphosphonate conjugates for osteoporosis treatment'20179,315,504'Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof'20169,119,884'LLP2A-bisphosphonate conjugates for osteoporosis treatment'20158,779,139'Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof'20148,309,722'Substituted heterocycle gamma-carbolines synthesis'20127,504,430'Maleiimide anti-tumor phosphatase inhibitors'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2020Based in New Milford, NJ, US· patent location history
2012–2020Patents assigned to INTRA CELLULAR THERAPIES INC (11)· patent assignee history
2012–2015Patents assigned to YAO WEI (3)· patent assignee history
2012–2014Patents assigned to BEARD JAMES DAVID (2)· patent assignee history
2012–2014Patents assigned to CHENG HUA (2)· patent assignee history
2015–2019Patents assigned to UNIV CALIFORNIA (3)· patent assignee history
2015Based in Oakland, CA, US· patent location history
2017–2019Based in El Dorado Hills, CA, US· patent location history
2021Based in Kunshan, CN· patent location history
2021Based in Hsinchu County, TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INTRA CELLULAR THERAPIES INC112012–2020
UNIV CALIFORNIA32015–2019
YAO WEIself32012–2015
BEARD JAMES DAVID22012–2014
CHENG HUA22012–2014
Locations
LocationPatentsSpan
New Milford, New Jersey, US122009–2020
El Dorado Hills, California, US22017–2019
Kunshan, CN12021
Hsinchu County, TW12021
Oakland, California, US12015